Ordinary benefitAs of September 2026, Medicare Part D remains free to refuse coverage of a medicine prescribed for weight loss.
As of September 2026, that same drug can still qualify for coverage if the prescription is for a different accepted condition, diabetes or heart problems for example.
Even then, each plan keeps its own list of covered drugs and may insist on approving the medicine before it pays.
Short-term programAs of September 2026, Medicare has a temporary trial program running July 1, 2026 to December 31, 2027, under which eligible Part D members pay $50 monthly for some weight-loss medicines.
Eligibility turns on your weight and any other health conditions, and you must be at least 18. People with type 2 diabetes are left out, because their medicine is already covered the usual way.
Ask your prescriber or your Part D plan whether you qualify. The program is not a permanent change to Medicare’s usual rule.